Diamedica Therapeutics (DMAC) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Diamedica Therapeutics Inc. has filed a Form 8-K with the SEC, detailing a current report that could impact its stock, traded under the symbol DMAC on The Nasdaq Stock Market LLC. The report, dated May 8, 2024, pertains to the company, headquartered in Minneapolis, Minnesota, which is not classified as an emerging growth company.
For further insights into DMAC stock, check out TipRanks’ Stock Analysis page.
